SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 28th, 2012 • Morria Biopharmaceuticals PLC • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 3, 2012, is by and among Morria Biopharmaceuticals PLC, a public limited company formed under the laws of England and Wales (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
DEPOSIT AGREEMENT by and among MORRIA BIOPHARMACEUTICALS PLC AND DEUTSCHE BANK TRUST COMPANY AMERICAS as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS ISSUED HEREUNDER Dated...Deposit Agreement • June 28th, 2012 • Morria Biopharmaceuticals PLC • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 28th, 2012 • Morria Biopharmaceuticals PLC • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 4, 2012, is by and among Morria Biopharmaceuticals PLC, a public limited company formed under the laws of England and Wales (the “Company”), and each of the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
EXECUTIVE SERVICE AGREEMENT MORRIA BIOPHARMACEUTICALS PLC and Dov ElefantExecutive Service Agreement • June 28th, 2012 • Morria Biopharmaceuticals PLC
EXECUTIVE SERVICE AGREEMENT MORRIA BIOPHARMACEUTICALS PLC and Alan Harris PARTIES:Executive Service Agreement • June 28th, 2012 • Morria Biopharmaceuticals PLC
GUARANTYGuaranty • June 28th, 2012 • Morria Biopharmaceuticals PLC • New York
This Guaranty (the “Guaranty”) is made this 4th day of April 2012, by such guarantors listed on the signature pages hereof (collectively, jointly and severally, “Guarantors,” and each, individually, a “Guarantor”), in favor of each of the investors listed on the Schedule of Buyers attached to the Securities Purchase Agreement (as defined herein) (each, individually, a “Buyer” and together with their respective successors, assigns, endorsees and transferees, the “Buyers”).
ContractMorria Biopharmaceuticals PLC • June 28th, 2012
Yissum Research Development Company of the Hebrew University of Jerusalem HI Tech Park, Edmond J. Safra Campus Givat Ram, PO Box 3S13S Jerusalem 91390, Israel
Yissum Research Development Company of the Hebrew University of Jerusalem Edmond Safra Campus, Givat Ram, POB 39135 Jerusalem 91390 IsraelMorria Biopharmaceuticals PLC • June 28th, 2012
We do hereby refer to the Agreement for the Rendering of Services dated as of June 20, 2005 (the "Service Agreement") and the extension thereto dated as of June 2006 ("Extension of Agreement for Rendering of Services") (jointly with the Services Agreement, the "Extended Service Agreement") and the License Agreement dated November 27th, 2002 (the "License Agreement") all executed by and between Yissum Research Development Company of the Hebrew University of Jerusalem ("Yissum") and Morria Biopharmaceuticals, Inc. (the "Company").
CONSULTING AGREEMENTConsulting Agreement • June 28th, 2012 • Morria Biopharmaceuticals PLC • New York
THIS AGREEMENT (the “Agreement”) dated December 15, 2010 ("Effective Date") is made by and between Morria Biopharmaceuticals, Plc., whose address is 53 Davies Street, Mayfaire, London (the “Company”); and AGH Associates having an address of 190 East 72nd Street Suite 32C, New York, NY 10021 (the “Consultant”).
Re: Third Extension of Agreement for rendering of ServicesMorria Biopharmaceuticals PLC • June 28th, 2012
We do hereby refer to the Agreement for the Rendering of Services dated as of June 20, 2005 (the "Service Agreement") and the extension thereto dated as of June, 20 2006 ("Extension of Agreement for Rendering of Services") (jointly with the Services Agreement, the "Extended Service Agreement") and the second extension thereto dated as of December 19, 2006 ("Second Extension of Agreement for Rendering of Services") and the License Agreement dated November 27th, 2002 (the "License Agreement") all executed by and between Yissum Research Development Company of the Hebrew University of Jerusalem ("Yissum") and Morria Biopharmaceuticals, Inc. (the "Company").
Re: Extension of Agreement for rendering of ServicesMorria Biopharmaceuticals PLC • June 28th, 2012
We do hereby refer to the Agreement for the Rendering of Services dated as of June 20, 2005 ("Service Agreement") and the License Agreement dated November 27, 2002, (the "License Agreement") by and between Yissum Research Development Company 0f the Hebrew University of Jerusalem ('Yissum") and Morria Biopharmaceuticals ("the Company'').
MORRIA BIOPHARMACEUTICALS PLCMorria Biopharmaceuticals PLC • June 28th, 2012
Reference is hereby made to the Executive Service Agreement dated 2007, as amended by an amendment letter dated as of March 8, 2007 (as so amended, the “Executive Agreement”), between Morria Biopharmaceuticals Plc. (the “Company” or "Morria Plc.") and you. The Company has employed you in the position of President of the Company under the Executive Agreement.
Morria letter head/Morria Biopharmaceuticals PLC • June 28th, 2012
We do hereby refer to the Agreement for the Rendering of Services dated as of June 20, 2005 (the "Service Agreement"); the extension thereto dated as of June, 20 2006 (the "Extension of Agreement for Rendering of Services"); the second extension thereto dated as of December 19, 2006 (the "Second Extension of Agreement for Rendering of Services"); the third extension thereto dated as of June 17, 2007; and the fourth extension thereto dated May 6, 2008 (the "Fourth Extension of Agreement for Rendering of Services") (collectively, the "Extended Service Agreements") (all executed by and between Yissum Research Development Company of the Hebrew University of Jerusalem ("Yissum") and Morria Biopharmaceuticals, PLC, a UK company (the "Company"), and the License Agreement dated November 27th, 2002 (the "License Agreement"), executed by and between Yissum Research Development Company of the Hebrew University of Jerusalem ("Yissum") and Morria Biopharmaceuticals, Inc. ("Morria Inc."), which Lice
SECURITY AGREEMENTSecurity Agreement • June 28th, 2012 • Morria Biopharmaceuticals PLC • New York
